Table 1.
Demographic and clinical profiles for ADHD subjects.
| ID | Age (years) |
Sex | ADHD subtype | Complication | WISC-III full IQ | MPH dose (mg) |
Duration of MPH exposure (years) |
Other medications |
|---|---|---|---|---|---|---|---|---|
| 1 | 7 | M | Inattentive | None | 110 | 18 | 1.0 | None |
| 2 | 8 | M | Combined | None | 95 | 27 | 1.0 | None |
| 3 | 12 | M | Combined | PDD | 96 | 27 | 1.8 | None |
| 4 | 11 | M | Combined | None | 82 | 27 | 3.4 | None |
| 5 | 6 | F | Hyperactive | None | 98 | 18 | 0.6 | None |
| 6 | 7 | M | Combined | PDD | 79 | 18 | Naïve | None |
| 7 | 13 | M | Combined | None | 82 | 45 | 2.1 | Carbamazepine, risperidone |
| 8 | 8 | F | Combined | PDD | 85 | 18 | Naïve | None |
| 9 | 8 | F | Combined | Epilepsy | 85 | 18 | Naïve | Valproic acid |
| 10 | 8 | M | Combined | PDD | 101 | 18 | 2.0 | None |
| 11 | 8 | M | Combined | None | 90 | 27 | 2.2 | None |
| 12 | 7 | M | Combined | None | 95 | 18 | Naïve | None |
| 13 | 6 | F | Inattentive | None | 74 | 18 | Naïve | None |
| 14 | 10 | M | Combined | None | 105 | 18 | Naïve | None |
| 15 | 9 | M | Combined | None | 85 | 18 | Naïve | None |
| 16 | 12 | M | Combined | None | 90 | 18 | 0.1 | None |
| Mean | 8.8 | 90.8 | ||||||
| SD | 2.2 | 9.9 |
Abbreviations: SD, standard deviation; PDD: pervasive developmental disorders.